Are you Dr. Imielinski?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 19 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
101 Nicolls Rd
Boston, MA 11794Phone+1 617-726-2967
Summary
- Dr. Marcin Imielinski, MD is a board certified pathologist in Boston, Massachusetts. He is currently licensed to practice medicine in Massachusetts and New York. He is affiliated with New York-Presbyterian Hospital and is a Clinical Fellow in Pathology at Massachusetts General Hospital.
Education & Training
- Brigham and Women's Hospital/Harvard Medical SchoolFellowship, Molecular Genetic Pathology, 2011 - 2012
- Massachusetts General HospitalResidency, Pathology-Anatomic and Clinical, 2008 - 2011
- Perelman School of Medicine at the University of PennsylvaniaClass of 2008
Certifications & Licensure
- NY State Medical License 2015 - 2027
- MA State Medical License 2014 - 2015
- American Board of Pathology Pathology - Clinical
- American Board of Pathology Pathology - Molecular Genetic
Publications & Presentations
PubMed
- Modeling lung adenocarcinoma metastases using patient-derived organoids.Yuan Liu, Manendra Lankadasari, Joel Rosiene, Kofi E Johnson, Juan Zhou
Cell Reports. Medicine. 2024-10-15 - Comparison of germline and somatic structural variants in cancers reveal systematic differences in variant generating and selection processes.Wolu Chukwu, Siyun Lee, Alexander Crane, Shu Zhang, Sophie Webster
Biorxiv. 2024-06-18 - 8 citationsUltrasensitive plasma-based monitoring of tumor burden using machine-learning-guided signal enrichment.Adam J Widman, Minita Shah, Amanda Frydendahl, Daniel Halmos, Cole C Khamnei
Nature Medicine. 2024-06-01
Press Mentions
- Molecular Pathology Selected AbstractsOctober 22nd, 2022
- Whole Exome Sequencing Predicts Whether Patients Respond to Cancer ImmunotherapyJuly 12th, 2022
- Two Investigators Win Pershing Square Sohn Prize for Cancer ResearchMay 28th, 2021
- Join now to see all